19-3186139-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020170.4(NCLN):āc.109C>Gā(p.Leu37Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000138 in 1,596,646 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020170.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NCLN | NM_020170.4 | c.109C>G | p.Leu37Val | missense_variant | 1/15 | ENST00000246117.9 | NP_064555.2 | |
NCLN | NM_001321463.2 | c.109C>G | p.Leu37Val | missense_variant | 1/15 | NP_001308392.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NCLN | ENST00000246117.9 | c.109C>G | p.Leu37Val | missense_variant | 1/15 | 1 | NM_020170.4 | ENSP00000246117.3 | ||
NCLN | ENST00000588428.5 | c.109C>G | p.Leu37Val | missense_variant | 1/9 | 5 | ENSP00000467011.1 | |||
NCLN | ENST00000590671.5 | c.-39+183C>G | intron_variant | 2 | ENSP00000466678.1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152166Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000671 AC: 15AN: 223622Hom.: 0 AF XY: 0.0000729 AC XY: 9AN XY: 123520
GnomAD4 exome AF: 0.000145 AC: 209AN: 1444480Hom.: 0 Cov.: 34 AF XY: 0.000136 AC XY: 98AN XY: 718730
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152166Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 26, 2024 | The c.109C>G (p.L37V) alteration is located in exon 1 (coding exon 1) of the NCLN gene. This alteration results from a C to G substitution at nucleotide position 109, causing the leucine (L) at amino acid position 37 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at